ATS 2019 Virtual Final Program

BEHAVIORAL • CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 B90 BIG TOBACCO: LAWYERS, GUNS AND MONEY Assemblies on Thoracic Oncology; Behavioral Science and Health Services Research 2:15 p.m. - 4:15 p.m. KBHCCD Ballroom A Two (Level 2) Target Audience Physicians both in training and in practice, Nurses, DNP, ARNP RN, Health Science administrators, Health policy leaders. Health services researches and population health researchers Objectives At the conclusion of this session, the participant will be able to: • gain new findings regarding the tobacco settlement between tobacco companies and the states and its impact more than a decade later; • understand and gain new findings about the role investment, financing and advertising play in tobacco and potential advocacy roles to check this influence; • gain new findings regarding tobacco policy and the shift to E and vapor Tobacco related diseases are at the core of the ATS mission. Clinical care is the majority focus of clinicians and the ATS membership. Advocacy and policy work surrounding tobacco is critical to the ATS mission, the ATS community of clinicians, administrators and researchers and most importantly patients. This session aims to explore the much talked about tobacco settlement, the influence of finance and investing as well as the role of advertising. It is critical to learn and engage in the greater policy debate around the tobacco message. Chairing: J.A. Gorden, MD, Seattle, WA N.T. Tanner, MD, MSCR, Charleston, SC D.A. Arenberg, MD, Ann Arbor, MI 2:15 Introduction J.A. Gorden, MD, Seattle, WA 2:20 Tobacco Settlement: What Was It and Where Did It Go K.M. Cummings, PhD, MPH, Charleston, SC 2:43 E Cigarette and Vape Pen Science: Technology Solution or Problem? D.A. Arenberg, MD, Ann Arbor, MI 3:06 Tobacco Policy: Stick and Match to E's and Vapes Are We Witnessing the Greatest Bate and Switch E. Stone, MBBS, MMed, Darlinghurst, Australia 3:29 E-Cigs and Vaping for Smoking Cessation: Winning by Quitting or Double Trouble? M. Carpenter, PhD, Charleston, SC 3:52 Tobacco Control and Public Policy: Keeping Up with the Changes C. Douglas, JD, Ann Arbor, MI BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 B91 HAVE A BIGGER IMPACT! EFFECTIVE STRATEGIES TO UTILIZE YOUR PROFESSIONAL EXPERTISE TO ADVOCATE FOR YOUR PATIENTS AND YOUR COMMUNITIES Assemblies on Environmental, Occupational and Population Health; Behavioral Science and Health Services Research; Nursing; Pediatrics 2:15 p.m. - 4:15 p.m. KBHCCD Room D163/D165/D170/D172 (Level 1) Target Audience All individuals who are interested in learning how to advocate for their individual patients, communities and populations at large, to improve to the availability and quality of healthcare Objectives At the conclusion of this session, the participant will be able to: • learn the types of advocacy approaches that have been effective in advancing respiratory health for individual patients, communities and larger populations; • develop communication skills to effectively advocate through multiple media formats including editorials, broadcast, social media, and public speaking engagements; • learn from examples of successful advocacy programs and understand a framework through which advocacy can implement change. This session will describe effective strategies to advance the respiratory health of patients, communities and populations.The Vice President of ATS will first introduce advocacy from the ATS perspective. Two public relations and media experts will then discuss effective communication strategies to disseminate health information and advocate for respiratory health issues through media. Subsequent speakers from the nonprofit sector, patient-advocacy groups, legal aid, and academics will highlight the health professional’s role in advocacy within the clinical environment, as well as through community partnerships, research and health policy. Chairing: D. Harris, MD, Charlottesville, VA M.B. Rice, MD, MPH, Boston, MA C.A. Redlich, MD, MPH, New Haven, CT S.J. Crowder, PhD, RN, ATSF, Fishers, IN L.F. Reinke, PhD, APRN, BC, ATS, Seattle,WA 2:15 Understanding The Importance of Advocacy for Respiratory Health J.C. Celedon, DrPH, MD, ATSF, Pittsburgh, PA 2:25 Using the Media to Increase Your Impact L. Kryzwick, New York, NY 2:50 Developing Engaging Health Messages M. Mackert, PhD, Austin, TX 3:15 Advocacy to Impact Public Policy and Legislation at the National and Local Level G. Ewart, MHS, Washington, DC ATS 2019 • Dallas, TX MONDAY • MAY 20 203 MONDAY AFTERNOON